Table 2.
Baseline scores (T0), twelve months scores (T1) and mean change scores with standard deviations.
| EORTC QLQ-C30 global health | EQ VAS | EQ 5D Index | |||||||||
| Subgroup | T0 | T1 | Δ (sd) | T0 | T1 | Δ (sd) | SRM | T0 | T1 | Δ (sd) | SRM |
| Moderate-large deterioration (n = 23) |
79.3 | 56.9 | -22.5 (10.8) |
73.0 | 59.8 | -13.2 (11.2) |
-1.17 | 0.72 | 0.57 | -0.15 (0.29) |
-0.52 |
| Small deterioration (n = 14) |
75.6 | 67.3 | -8.3 (0.0) |
74.4 | 69.4 | -5.1 (12.0) |
-0.42 | 0.73 | 0.72 | -0.01 (0.18) |
-0.05 |
| No change (n = 55) |
80.9 | 80.9 | 0.0 (0.0) |
79.0 | 79.9 | 0.7 (8.8) |
0.08 | 0.82 | 0.82 | 0.00 (0.21) |
0.01 |
| Small improvement (n = 28) |
71.2 | 80.1 | 8.3 (0.0) |
70.9 | 77.7 | 6.1 (7.7) |
0.79 | 0.78 | 0.80 | 0.02 (0.14) |
0.16 |
| Moderate-large improvement (n = 72) |
58.2 | 85.6 | 27.4 (11.9) |
65.0 | 77.4 | 12.1 (12.7) |
0.95 | 0.71 | 0.83 | 0.13 (0.20) |
0.62 |
SRMs of the EQ VAS and EQ-5D Index for all subgroups of patients.